Organization
Technical University of Denmark – DTU, HEALTH TECH, Department of Health Technology, Lyngby, Denmark
3 abstracts
Abstract
Final results: Dose escalation study of a personalized peptide-based neoantigen vaccine in patients with metastatic melanoma.Org: National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark, Technical University of Denmark – DTU, HEALTH TECH, Department of Health Technology, Lyngby, Denmark, National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark, Center for Cancer Immune Therapy-CCIT Herlev Hospital (Denmark), Herlev, Denmark, Evaxion Biotech, Hoersholm, Denmark,
Abstract
A NEO-EPITOPE FRAGMENT OF CARTILAGE DEGRADATION GENERATED FROM TYPE II COLLAGEN PROCESSING: A NOVEL SERUM BIOMARKER TO ACCESS TYPE II COLLAGEN DEGRADATION IN JOINT DEGENERATIVE DISEASESOrg: Nordic Bioscience A/S, Copenhagen, Denmark, Copenhagen University Hospital, Lund University, Technical University of Denmark – DTU, HEALTH TECH, Department of Health Technology, Lyngby, Denmark,
Abstract
A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASESOrg: Nordic Bioscience, Lund University, University of Aalborg, Technical University of Denmark – DTU, HEALTH TECH, Department of Health Technology, Lyngby, Denmark,